Indocyangreen Elimination in Cirrhosis and Acute Liver Failure

Heidelberg University40 enrolled

Overview

Indocyangreen (ICG)is totally biliary eliminated and corresponds to hepatocyte function and liver perfusion. The ICG-clearance will be evaluated as a prognostic marker in liver disease.

patients with acute liver failure or advanced liver disease will be studied. ICG-clearance will be correlated with established clinical scores and outcome.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Acute Liver Failure Liver Cirrhosis

Interventions

Indocyangreen (ICG) clearancePROCEDURE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * acute liver failure OR end-stage liver disease * normal hepatic perfusion by doppler ultrasound Exclusion Criteria: * portal vein thrombosis * allergy to ICG or iodine * thyroid disease

Locations (1)

University of Heidelberg

Heidelberg, Germany

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.